| 摘要 |
Nanoparticles of PX compounds in the size range of 10 to 1000 nanometers are incorporated into formulations that are safe for intravenous administration and used to treat disease conditions caused by phospholipase A2 (PLA2) such as ischemia-reperfusion injury.
|
